S
Sven Seys
Researcher at Katholieke Universiteit Leuven
Publications - 101
Citations - 3823
Sven Seys is an academic researcher from Katholieke Universiteit Leuven. The author has contributed to research in topics: Asthma & Sputum. The author has an hindex of 31, co-authored 90 publications receiving 2715 citations. Previous affiliations of Sven Seys include Université catholique de Louvain & Catholic University of Leuven.
Papers
More filters
Journal ArticleDOI
Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology
Antonella Muraro,Robert F. Lemanske,Peter Hellings,Cezmi A. Akdis,Thomas Bieber,Thomas B. Casale,Marek Jutel,Peck Y. Ong,Lars K. Poulsen,Peter Schmid-Grendelmeier,Hans-Uwe Simon,Sven Seys,Ioana Agache +12 more
TL;DR: This consensus document is summarized the current knowledge on major asthma, rhinitis, and atopic dermatitis endotypes under the auspices of the PRACTALL collaboration platform.
Journal ArticleDOI
Impaired barrier function in patients with house dust mite-induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression.
Brecht Steelant,Ricard Farré,Paulina Wawrzyniak,Jochen Belmans,Emily Dekimpe,Hanne Vanheel,Laura Van Gerven,Inge Kortekaas Krohn,Dominique Bullens,Jan Ceuppens,Cezmi A. Akdis,Guy E. Boeckxstaens,Sven Seys,Peter Hellings +13 more
TL;DR: In this article, the expression, function, and regulation of tight junction (TJ) defects in the nasal epithelium of patients with house dust mite (HDM) induced AR and in an HDM-induced murine model of allergic airway disease were investigated.
Journal ArticleDOI
EUFOREA consensus on biologics for CRSwNP with or without asthma
Wytske Fokkens,Valerie J. Lund,Claus Bachert,Claus Bachert,Joaquim Mullol,Leif Bjermer,Jean Bousquet,Giorgio Walter Canonica,L Deneyer,Martin Desrosiers,Zuzana Diamant,Zuzana Diamant,Joseph K. Han,Enrico Heffler,Claire Hopkins,Roger Jankowski,Guy Joos,Andrew Knill,Jivianne T. Lee,Stella E. Lee,Gert Marien,Benoit Pugin,Brent A. Senior,Sven Seys,Peter Hellings +24 more
TL;DR: Novel therapies such as type 2 targeting biologics are emerging treatment options for patients with chronic inflammatory respiratory diseases, fulfilling the needs of severely uncontrolled patients and may soon also become available for CRSwNP patients.
Journal ArticleDOI
Research needs in allergy: an EAACI position paper, in collaboration with EFA
Nikolaos G. Papadopoulos,Ioana Agache,Sevim Bavbek,B. M. Bilo,Fulvio Braido,Victoria Cardona,Adnan Custovic,Jan Demonchy,Pascal Demoly,Philippe Eigenmann,Jacques Gayraud,Clive Grattan,Enrico Heffler,Peter Hellings,Marek Jutel,Edward F. Knol,Jan Lötvall,Antonella Muraro,Lars K. Poulsen,Graham Roberts,Peter Schmid-Grendelmeier,Chrysanthi Skevaki,Massimo Triggiani,Ronald Vanree,Thomas Werfel,Breda Flood,Susanna Palkonen,Roberta Savli,Pia Allegri,Isabella Annesi-Maesano,Francesco Annunziato,Darío Antolín-Amérigo,Christian Apfelbacher,Miguel Blanca,Ewa Bogacka,Patrizia Bonadonna,Matteo Bonini,Onur Boyman,Knut Brockow,Peter Burney,Jeroen Buters,Indre Butiene,Moises A. Calderon,Lars-Olaf Cardell,Jean-Christoph Roger J-P Caubet,Sevcan Celenk,Ewa Cichocka-Jarosz,Cemal Cingi,Mariana Couto,Nicolette W. deJong,Stefano Del Giacco,Nikolaos Douladiris,Filippo Fassio,Jean-Luc Fauquert,Javier Fernández,Montserrat Fernandez Rivas,Marta Ferrer,Carsten Flohr,James Gardner,Jon Genuneit,Philippe Gevaert,Anna Groblewska,Eckard Hamelmann,Hans Jürgen Hoffmann,Karin Hoffmann-Sommergruber,Lilit Hovhannisyan,Valérie Hox,Frode L. Jahnsen,Ömer Kalayci,Ayse Fusun Kalpaklioglu,Jörg Kleine-Tebbe,George N. Konstantinou,Marcin Kurowski,Susanne Lau,Roger Lauener,Antti Lauerma,Kirsty Logan,Antoine Magnan,Joanna Makowska,Heidi Makrinioti,Paraskevi Mangina,Felicia Manole,Adriano Mari,Angel Mazon,Clare Mills,Ervinç Mingomataj,Bodo Niggemann,Gunnar Nilsson,Markus Ollert,Liam O'Mahony,Serena O'Neil,Gianni Pala,Alberto Papi,Gianni Passalacqua,Michael R. Perkin,Oliver Pfaar,Constantinos Pitsios,Santiago Quirce,Ulrike Raap,Monika Raulf-Heimsoth,Claudio Rhyner,Paula Robson-Ansley,Rodrigo Rodrigues Alves,Zeljka Roje,Carmen Rondon,Odilija Rudzeviciene,Franziska Ruëff,Maia Rukhadze,Gabriele Rumi,Cansin Sackesen,Alexandra F. Santos,Alexandra F. Santos,Annalisa Santucci,Christian Scharf,Carsten B. Schmidt-Weber,B Schnyder,Jürgen Schwarze,Gianenrico Senna,Svetlana Sergejeva,Sven Seys,Andrea Siracusa,Isabel Skypala,Milena Sokolowska,François Spertini,Radoslaw Spiewak,Aline B. Sprikkelman,Gunter J. Sturm,Ines Swoboda,Ingrid Terreehorst,Elina Toskala,Claudia Traidl-Hoffmann,Carina Venter,Berber Vlieg-Boerstra,Paul Whitacker,Margitta Worm,Paraskevi Xepapadaki,Cezmi A. Akdis +136 more
TL;DR: The present EAACI Position Paper, in collaboration with EFA, highlights the most important research needs in the field of allergy to serve as key recommendations for future research funding at the national and European levels.
Journal ArticleDOI
Mortality in non-cystic fibrosis bronchiectasis: A prospective cohort analysis
TL;DR: NCFB patients with associated COPD disease had the highest mortality rates compared to the other NCFB patients, and additional risk factors for lower survival were increasing age and number of lobes affected.